Home » Lilly Selling Rights to Medicine
Lilly Selling Rights to Medicine
Adolor Corp. is paying as much as $72 million for rights to Eli Lilly and Co.’s OpRA III, an experimental medicine to restore bowel function in people taking narcotic painkillers.
IndyStar
IndyStar
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May